Allianz Global Investors Fund - Allianz Europe Equity Growth AT H-CHFRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 20.2 | 26.8 | -22.5 | 21.4 | -3.6 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 21/11/2024 | CHF 227.82 | |
Day Change | -0.71% | |
Morningstar Category™ | Other Equity | |
ISIN | LU0837062107 | |
Fund Size (Mil) 21/11/2024 | EUR 3138.02 | |
Share Class Size (Mil) 21/11/2024 | CHF 43.61 | |
Max Initial Charge | - | |
Ongoing Charge 18/10/2024 | 1.85% |
Investment Objective: Allianz Global Investors Fund - Allianz Europe Equity Growth AT H-CHF |
Long-term capital growth by investing in European Equity Markets with a focus on growth stocks in accordance with e/s characteristics. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Andreas Hildebrand 10/10/2023 | ||
Giovanni Trombello 10/10/2023 | ||
Click here to see others | ||
Inception Date 22/10/2012 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P Europe LargeMidCap Growth NR USD | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Allianz Global Investors Fund - Allianz Europe Equity Growth AT H-CHF | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 7.85 |
ASML Holding NV | Technology | 6.87 |
DSV AS | Industrials | 5.51 |
SAP SE | Technology | 4.89 |
Sika AG | Basic Materials | 3.87 |
Increase Decrease New since last portfolio | ||
Allianz Global Investors Fund - Allianz Europe Equity Growth AT H-CHF |